Abstract
Aspiration may contribute to non-alloimmune lung allograft injury and eventual loss. Medical and surgical interventions have been advocated including fundoplication, but there is no consensus about when this should be carried out. Biomarker approaches, including measuring pepsin and bile salts have been proposed to document aspiration, and may potentially inform treatment, but there are few longitudinal studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.